A new research-backed initiative sees physicians recommending trips to Sweden for the health benefits. STOCKHOLM, Sept. 23, 2025 -- A sauna in Swedish Lapland for better sleep quality, or cold plunges in the archipelago for improved circulation? Two out of three respondents in a new international survey would be open to spending more time in nature if a doctor prescribed it. Now, Sweden is positioning itself as the world's first country to which travel can be prescribed by a doctor. Watch how experiences in Sweden can boost health: www.youtube.com/watch?v=hqo3PZwOZhk&nbs
MELBOURNE, Australia, Sept. 23, 2025 -- IMRA Surgical, an Australian-based company at the forefront of disruptive technology for surgical training solutions announces a collaboration with Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") a global leader in radiopharmaceuticals. Both parties aim to accelerate the development of advanced training models and enhance the integration of cutting-edge radio-guided surgical technologies. Strengthening Surgical Precision with SENSEI® in Robotic-Assisted Surgery Telix's innovative SENSEI&re
BEIJING, Sept. 22, 2025 -- China is actively addressing the challenges of an aging population. As the senior population grows and their spending habits evolve, the silver economy is emerging as a driver of economic growth and industrial development. From optimizing consumption patterns to expanding emerging industries, from applying smart technologies to improving medical and elderly care services, the silver economy is becoming a new engine propelling multiple sectors forward.Younger seniors are the main force in China's silver economy, and their consumption needs are becoming increasingly d
BEIJING, Sept. 22, 2025 -- China's silver economy is not only transforming the lives of its senior citizens but also reshaping the global conversation about how societies should respond to demographic change. With medium-speed growth in per capita consumption, the scale of China's silver economy is projected to reach 19.1 trillion yuan ($2.68 trillion) by 2035, accounting for nearly 28 percent of total consumption, according to the Fudan Institute on Aging. Far from being a passive challenge, aging in China is being actively turned into a source of innovation, new industries, and internationa
[ 메디채널 황정호 기자 ] A new platform gives communicators the tools to transform a single press release into a full-scale campaign, ensuring their message breaks through to global audiences and AI alike. NEW YORK, Sept. 22, 2025 -- In a world where consolidating newsrooms and AI-driven search are redefining how stories are discovered, the press release is increasingly the bedrock of credible, trusted, brand communication. When used as the foundation for a robust multichannel communications strategy it accelerates message reach and effectiveness, while ensuring an authenticated message direc
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities SEOUL, South Korea, Sept. 22, 2025 -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, and Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, today announced a nonexclusive collaboration to develop AI-based companion diagnostic solutions. The collaboration will leverage Lunit's AI technology and Agilent's expertise in t
[ 메디채널 김갑성 기자 ] Study confirms the novelty and atomic-level precision of de novo antibody design, including cryo-EM validation on a designed anti-PD-L1 antibody Findings highlight broad therapeutic applicability across oncology, immune, and metabolic diseases SEOUL, South Korea, Sept. 22, 2025 -- Galux, a South Korea–based biotech company pioneering AI-driven protein therapeutics design, today announced new results that further validate its de novo antibody design platform, GaluxDesign. The findings showcase the platform's ability to generate novel antibodies that meet precise st
BOSTON, Sept. 22, 2025 -- SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) from the World CB & CDx Summit in Boston. The companies aim to improve the diagnosis and treatment of breast and prostate cancer by developing an optimized next generation sequencing (NGS) solution that leverages SOPHiA GENETICS's AI algorithms to detect genetic mutations in the PIK3CA/AKT1/PTEN pathway. The PIK3CA/AKT1/PTEN pathway is a key molecular signaling network tha
BEIJING, Sept. 22, 2025 -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that effective with the opening of business today, September 22, 2025, the Company's ordinary shares and warrants have been suspended from trading on The Nasdaq Capital Market ("Nasdaq"). On the same day, the Company's ordinary shares and wa
Raises $150,000 to support ALS research and youth swim education CHICAGO, Sept. 22, 2025 -- The Chicago River Swim returned on Sunday, September 21, for the first time in 98 years, marking a historic milestone for the city and drawing thousands of swimmers, civic leaders and spectators to the heart of downtown. The event, produced by the nonprofit A Long Swim, celebrated decades of environmental progress while raising $150,000 for ALS research at the Ozdinler Lab of Northwestern's Feinberg School of Medicine and swim-safety education programs at the Salvation Arm